Investor Center
Infinity Medical was established to harness innovative startups and bring digital health solutions to the world. Our focus is on advanced digital health technologies, with portfolio companies on the cutting edge of health innovation, in transition from development to global sales. Infinity medical team consists of experts in the fields of medicine, technology, business and finance. Our experience and confidence are reflected in our public company status (TASE:IMED.L).
IMED.L
Ticker
345
Last price
0%
Change
Last update: 16:38 03/04/22 (GMT +3)
From The Press
Sinopharm, the developer of the Chinese vaccine, is starting operations in Israel
Infinity Medical (IMED) has signed a partnership with GuoJian Capital who manages 130…
Prof. Rivka Carmi has been appointed a director of the Infinity Medical R&D partnership
Prof. Rivka Carmi, former President of Ben-Gurion University, has been appointed director of…
The Chinese capital market is expected to become the equivalent of Wall Street in about a decade
With a meteoric rise in business activity and the IPO market alongside government…
Three doctors tell why they preferred to change direction towards the business world
In an interview with Walla, Dr. Yuval Bloch, CEO of Infinity Medical, explains…
China opens its bond market to foreign investors for the first time
A series of additional steps that China is taking for the first time…
Infinity Medical has signed a cooperation agreement with a Chinese investment company from the Sinopharm Group
Chinese Synopharm belongs to the group of companies from which the Chinese vaccine…
What is expected in 2021 in the field of digital health?
“The Corona virus uncovered the failures of the healthcare system, one of them…
China’s Capital Markets Webinar
China’s Capital Market: The Main Growth Engine of 2020s Foreign Capital Opportunities in…
Infinity Medical announces a $750,000 investment in Nanomedic
Nanomedic has developed an innovative and first-of-its-kind device - “Electrospinning Portable”, for the…
Sinopharm, the developer of the Chinese vaccine, is starting operations in Israel
Infinity Medical (IMED) has signed a partnership with GuoJian Capital who manages 130…
Prof. Rivka Carmi has been appointed a director of the Infinity Medical R&D partnership
Prof. Rivka Carmi, former President of Ben-Gurion University, has been appointed director of…
The Chinese capital market is expected to become the equivalent of Wall Street in about a decade
With a meteoric rise in business activity and the IPO market alongside government…
Three doctors tell why they preferred to change direction towards the business world
In an interview with Walla, Dr. Yuval Bloch, CEO of Infinity Medical, explains…
China opens its bond market to foreign investors for the first time
A series of additional steps that China is taking for the first time…
Infinity Medical has signed a cooperation agreement with a Chinese investment company from the Sinopharm Group
Chinese Synopharm belongs to the group of companies from which the Chinese vaccine…
What is expected in 2021 in the field of digital health?
“The Corona virus uncovered the failures of the healthcare system, one of them…
China’s Capital Markets Webinar
China’s Capital Market: The Main Growth Engine of 2020s Foreign Capital Opportunities in…
Infinity Medical announces a $750,000 investment in Nanomedic
Nanomedic has developed an innovative and first-of-its-kind device - “Electrospinning Portable”, for the…
